Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10
- Add to watchlist
- Create an alert
- This stock can be held in a
1,932.00p
1,959.13p
2,165.00p
£4.33 bn
1,935.00p
1,918.00p
1,750.00p
10.84
7.00p (0.36%) Previous:
7.00p
843,155
2.94%
500
Performance
1 week 1W | 0.98% | 1 year 1Y | 8.08% |
---|---|---|---|
1 month 1M | 5.85% | 2 years 2Y | 27.86% |
3 months 3M | 2.68% | 3 years 3Y | 10.78% |
6 months 6M | 2.35% | 5 years 5Y | 2.88% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 2,875.00 | 2,517.00 |
Profit before tax ($m) | 281.00 | 233.00 |
Adjusted EPS (¢): | 223.00 | 181.00 |
P/E ratio | 10.10 | 10.80 |
PEG | 0.40 | n/a |
EPS growth (%) | 23.00 | (7.00) |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by Hikma Pharmaceuticals:
Type | Ex-div date | Payment date | Amount |
---|---|---|---|
Interim | 15/08/2024 | 20/09/2024 | 32.00¢ |
Final | 21/03/2024 | 03/05/2024 | 47.00¢ |
Interim | 10/08/2023 | 15/09/2023 | 25.00¢ |
Final | 23/03/2023 | 05/05/2023 | 37.00¢ |
Interim | 18/08/2022 | 20/09/2022 | 19.00¢ |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual Hikma Pharmaceuticals dividends:
Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
---|---|---|---|
31/12/2023 | 3.20% | 3.10 | $0.72 |
31/12/2022 | 2.90% | 3.23 | $0.56 |
31/12/2021 | 1.90% | 3.61 | $0.54 |
31/12/2020 | 1.60% | 3.46 | $0.50 |
31/12/2019 | 1.80% | 3.42 | $0.44 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
Important Documents
There are no documents available for this stock.
-
London close: Stocks finish lower as Ashtead announces US move
10 December 2024 16:03
-
RBC upgrades Hikma Pharmaceuticals to 'outperform'
10 December 2024 08:02
-
Hikma reiterates outlook on strong trading
7 November 2024 08:19
-
Outcome of Audit Tender Process
7 November 2024 15:30
-
Trading Statement
7 November 2024 07:00
-
2024 Annual General Meeting Update Statement
24 October 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.